Larsson A, Bålöw R M, Lindahl T L, Forsberg P O
Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.
Poult Sci. 1993 Oct;72(10):1807-12. doi: 10.3382/ps.0721807.
Laying hens are highly cost-effective as producers of antibodies compared with the mammals traditionally used for such production. Also, chicken antibodies have biochemical advantages over mammalian antibodies due to the phylogenetical differences between avian and mammalian species, resulting in increased sensitivity as well as decreased background in immunological assays. In contrast to mammalian antibodies, chicken antibodies do not activate the human complement system nor will they react with rheumatoid factors, human anti-mouse IgG antibodies, or bacterial and human Fc (fragment crystallizable)-receptors. Thus, chicken antibodies offer many advantages over mammalian antibodies and may replace such antibodies in the future.
与传统用于生产抗体的哺乳动物相比,蛋鸡作为抗体生产者具有很高的成本效益。此外,由于禽类和哺乳动物物种之间的系统发育差异,鸡抗体在生化方面优于哺乳动物抗体,这导致免疫测定中的灵敏度提高以及背景降低。与哺乳动物抗体不同,鸡抗体不会激活人类补体系统,也不会与类风湿因子、人抗小鼠IgG抗体或细菌及人类Fc(可结晶片段)受体发生反应。因此,鸡抗体比哺乳动物抗体具有许多优势,未来可能会取代此类抗体。